Valeant Pharmaceuticals Intl Inc Stock Is Worth the Risk
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) has begun a turnaround. The Laval, Canada-based drug manufacturer is on a growth path again after VRX stock came crashing from lofty highs. A new CEO now works to drive profits and reduce a heavy debt burden.
Source:: https://finance.yahoo.com/news/valeant-pharmaceuticals-intl-inc-stock-102951212.html
